Lundbeck to delist in US
The pharmaceutical firm’s new share structure means that Lundbeck is terminating its trading program in the US.
by mikkel aabenhus hemmingsen, translated by daniel pedersen
US investors will soon be unable to trade Lundbeck shares in their own currency and during US stock exchange opening hours.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Lundbeck faces criticism over new share structure
For subscribers
